Genewiz, KeyTest Collaborate on MDx Development in China | GenomeWeb

NEW YORK (GenomeWeb News) – Genewiz and KeyTest Diagnostics today announced a collaboration aimed at developing molecular diagnostic tests for the Chinese market.

In addition to developing tests using cutting-edge genomics technologies, the partners said they aim to establish clinical testing standards.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.